HealthFinSMEsabout 2 hours ago
Mentara Therapeutics Raises Initial Funding
1 min read
Melbourne-based Mentara Therapeutics raised an undisclosed amount of capital in its initial strategic financing round. Backers include SPRIM Global Investments and former EuMentis shareholders. The company plans to launch a Phase 2 clinical study in the first half of 2027 evaluating its core asset for levodopa-induced dyskinesia in Parkinson's disease patients.
Level
Hype check
Tap to vote and see what everyone thinks.
